Press Release: TOPICA Begins Phase 2 Clinical Trial Of Potent Antifungal, Luliconazole, In Athlete’s Foot TOPICA Pharmaceuticals announced the enrollment of patients in a Phase 2 clinical trial evaluating luliconazole for the treatment of tinea pedis (athlete’s foot). Luliconazole, the company’s lead product candidate, is the one of the most potent and broad spectrum molecules in… Click to expand…
Visit site:
Luliconazole for athletes foot